Active Plasmonic Scaffolds for Tissue Regeneration
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current tissue graft methods, such as autografts, allografts, and xenografts, face challenges including complex and painful harvesting processes, long recovery times, potential rejection, and disease transmission, necessitating the development of more effective and safer alternatives for tissue repair.
Innovation Solution
The development of two-dimensional (2D) and three-dimensional (3D) active plasmonic scaffolds made from polymer films and nanoparticles, with functional groups and active molecules like extracellular proteins and drugs, providing a biocompatible, drug-delivery capable, and tunable surface chemistry for enhanced tissue regeneration.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Reliability
If traditional tissue graft methods (autograft, allograft, xenograft) are used, then tissue repair can be achieved, but the treatment process becomes complex and painful with long recovery times
Solution Approach 1:
The invention segments the treatment approach by providing pre-fabricated tissue graft patches that can be directly applied to injured areas, eliminating the need for complex surgical harvesting and implantation procedures. The patches are prepared in advance with specific structures and bioactive molecules, allowing simple application to the injury site.
Solution Approach 2:
The tissue graft patches are pre-fabricated with desired structures, compositions, and bioactive molecules before clinical use. This preliminary preparation eliminates the need for complex intraoperative processing and reduces surgical time, allowing the patches to be directly applied to injury sites without extensive surgical intervention.
2Reliability
If traditional tissue graft methods are used, then tissue repair can be achieved, but hospitalization period and treatment cost increase
Solution Approach 1:
The treatment is segmented into a simple application process where pre-fabricated patches are directly applied to injury sites, eliminating the need for prolonged hospitalization for complex surgical procedures. The patches contain all necessary components for tissue regeneration, allowing outpatient treatment.
Solution Approach 2:
All preparatory work including scaffold fabrication, bioactive molecule incorporation, and patch formation is completed before clinical use. This preliminary action eliminates the need for extended hospital stays for procedural complexity, reducing both hospitalization time and associated costs.
3Reliability
If allograft or xenograft is used, then tissue repair can be achieved, but rejection and infection risks increase
Solution Approach 1:
The invention uses the patient's own cells (autologous cells) to populate the scaffold, making the graft immunologically compatible and eliminating rejection risks. The scaffold serves itself by providing a structure that guides the patient's own cells to regenerate tissue, avoiding the need for immunosuppression or risk of disease transmission.
Solution Approach 2:
The invention changes the fundamental parameter of cellular origin from allogeneic or xenogeneic sources to autologous sources. This parameter change eliminates immunological incompatibility and associated risks of rejection and infection, while maintaining tissue repair effectiveness.
4Ease of manufacture
If simple polymer scaffolds are used, then manufacturing is easy, but cell attachment and tissue regeneration are insufficient
Solution Approach 1:
The invention combines polymer scaffolds with nanoparticles and bioactive molecules to create composite structures. The polymer provides the basic framework and ease of manufacture, while the incorporated nanoparticles and bioactive molecules enhance cell attachment, proliferation, and tissue regeneration capabilities.
Solution Approach 2:
The invention applies different functional components to specific regions of the scaffold. Bioactive molecules and nanoparticles are localized at the scaffold surface or specific zones to enhance cell interaction where needed, while maintaining the overall simplicity of scaffold fabrication. This local functionalization improves tissue regeneration without complicating the overall manufacturing process.
Data Source
AI summary
A two dimensional (2D) active plasmonic scaffold includes a polymer film and one or more nanoparticle layers disposed on the polymer film. The nanoparticles has functional groups attached thereon. A three dimensional (3D) structure fabricated using the 2D scaffold.